About
Keywords: Oncology, translational research, drug response, preclinical models, ovarian cancer, colorectal cancer.
Group leader
Team
Emerging group leader
Oskar Marin Bejar(ELIMINAR)
Scientific coordinator
Arola Fortian(ELIMINAR)
Postdoctoral researcher
Sara Bystrup(ELIMINAR)
PhD student
Laura Torres Ribas
Master's student
Gemma Brull
Laboratory technician
Victor Fuster
Research lines
- Multi-omics approach to ovarian cancer research
- Organoid-based treatment testing tlatform to optimize cancer management
- The non-genetic tumor evolution focusing on cancer biology and understanding the cancer cell reprogramming to different insults
News
The CARE Annual Meeting reviews the program’s cancer research activity and sets priorities for the months ahead
The III CARE Annual Meeting, held on 5 December at BCIN, brought together the cancer research community of the Can Ruti Campus for a day focused on scientific dialogue, interdisciplinarity and future strategy.
A new cellular model reveals which mutations drive progression to myelodysplastic syndrome and leukemia in patients with GATA2 deficiency
A research team has created the first humanised cellular model to study GATA2 deficiency, a rare genetic disorder that predisposes individuals to severe blood conditions such as myelodysplastic syndrome and leukaemia. The study shows that, although the initial GATA2 mutation weakens haematopoietic stem cells, it is additional mutations -particularly in the SETBP1 gene- that drive disease progression.
Contact
(+34) 93 033 05 18